Literature DB >> 10603221

Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease.

A E Fiore1, O S Levine, J A Elliott, R R Facklam, J C Butler.   

Abstract

To estimate the effectiveness of pneumococcal polysaccharide vaccine, we serotyped isolates submitted to the Pneumococcal Sentinel Surveillance System from 1984 to 1996 from 48 vaccinated and 125 unvaccinated children 2 to 5 years of age. Effectiveness against invasive disease caused by serotypes included in the vaccine was 63%. Effectiveness against serotypes in the polysaccharide vaccine but not in a proposed seven-valent protein conjugate vaccine was 94%.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10603221      PMCID： PMC2640808          DOI： 10.3201/eid0506.990616

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  21 in total

1.  Pneumococcal vaccine. Efficacy and associated cost savings.

Authors:  C B Gable; S S Holzer; L Engelhart; R B Friedman; F Smeltz; D Schroeder; K Baum
Journal:  JAMA       Date:  1990-12-12       Impact factor: 56.272

2.  Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people.

Authors:  J E Sisk; A J Moskowitz; W Whang; J D Lin; D S Fedson; A M McBean; J F Plouffe; M S Cetron; J C Butler
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

3.  Bias due to misclassification in the estimation of relative risk.

Authors:  K T Copeland; H Checkoway; A J McMichael; R H Holbrook
Journal:  Am J Epidemiol       Date:  1977-05       Impact factor: 4.897

4.  A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children.

Authors:  S K Obaro; Z Huo; W A Banya; D C Henderson; M A Monteil; A Leach; B M Greenwood
Journal:  Pediatr Infect Dis J       Date:  1997-12       Impact factor: 2.129

5.  Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

Authors:  M B Rennels; K M Edwards; H L Keyserling; K S Reisinger; D A Hogerman; D V Madore; I Chang; P R Paradiso; F J Malinoski; A Kimura
Journal:  Pediatrics       Date:  1998-04       Impact factor: 7.124

6.  Prevention of pneumococcal infection in children with homozygous sickle cell disease.

Authors:  A B John; A Ramlal; H Jackson; G H Maude; A W Sharma; G R Serjeant
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-26

7.  Vaccination against Streptococcus pneumoniae in childhood: lack of demonstrable benefit in young Australian children.

Authors:  R M Douglas; H B Miles
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226

8.  The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

Authors:  E D Shapiro; A T Berg; R Austrian; D Schroeder; V Parcells; A Margolis; R K Adair; J D Clemens
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

9.  Effect of pneumococcal vaccination on upper respiratory tract infections in children. Design of a follow-up study.

Authors:  C Rosén; P Christensen; B Hovelius; K Prellner
Journal:  Scand J Infect Dis Suppl       Date:  1983

10.  Immunisation with a polyvalent pneumococcal vaccine. Effect of respiratory mortality in children living in the New Guinea highlands.

Authors:  I D Riley; F A Everingham; D E Smith; R M Douglas
Journal:  Arch Dis Child       Date:  1981-05       Impact factor: 3.791
View more
  6 in total

Review 1.  Vaccination of adolescents with chronic medical conditions: Special considerations and strategies for enhancing uptake.

Authors:  Annika M Hofstetter; Philip LaRussa; Susan L Rosenthal
Journal:  Hum Vaccin Immunother       Date:  2015-07-25       Impact factor: 3.452

2.  Structural basis of hyaluronan degradation by Streptococcus pneumoniae hyaluronate lyase.

Authors:  S Li; S J Kelly; E Lamani; M Ferraroni; M J Jedrzejas
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

Review 3.  Advances in pneumococcal vaccines: advantages for infants and children.

Authors:  Jolanta Bernatoniene; Adam Finn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Streptococcus pneumoniae: Invasion and Inflammation.

Authors:  Allister J Loughran; Carlos J Orihuela; Elaine I Tuomanen
Journal:  Microbiol Spectr       Date:  2019-03

5.  Pediatric Immunization Practices in Nephrotic Syndrome: An Assessment of Provider and Parental Knowledge.

Authors:  Cheryl L Tran; David T Selewski; Gia J Oh; Jonathan P Troost; Susan F Massengill; Samhar I Al-Akash; Shefali Mahesh; Rasheda Amin; Isa F Ashoor; Rahul Chanchlani; Mahmoud Kallash; Robert P Woroniecki; Debbie S Gipson
Journal:  Front Pediatr       Date:  2021-02-05       Impact factor: 3.418

Review 6.  Pneumococcal Immunization Strategies for High-Risk Pediatric Populations Worldwide: One Size Does Not Fit All.

Authors:  Theano Lagousi; Ioanna Papadatou; Petros Strempas; Elena Chatzikalil; Vana Spoulou
Journal:  Vaccines (Basel)       Date:  2021-11-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.